IGF-1 is well known for its effect on myocardial tissue, including stimulation of cardiac contractility, antiapoptotic effects and improved remodeling after MI by switching on a cascade of downstream pathways including activation of pAkt, MAPK and Bcl-xL [24], [25]. This evidence concerns the gene BCL2L1 and myocardial infarction.